OngoingEUCTR 2013-004776-35
This study is looking at whether Methylphenidate can help people with Cardiovascular functioning in Attention deficit hyperactivity disorder following 3 years of treatment with methylphenidate or Adolescents, Under 18. Participants receive the study medicine Methylphenidate and complete study visits and assessments.
ADHDOther
- Countries
- United Kingdom
- Sponsor
- Radboud University Medical Centre Nijmegen
- Condition
- ADHD
RecruitingISRCTN52338801
This feasibility trial is preparing to test psychodynamic interpersonal therapy for people experiencing psychosis. The ISRCTN record lists it as not yet recruiting.
SchizophreniaOtherFrom 18 Years to 100 Years
- Countries
- United Kingdom
- Sponsor
- Greater Manchester Mental Health NHS Foundation Trust
- Condition
- Schizophrenia
Not Yet RecruitingISRCTN11089633
This study will test Social Recovery Therapy for people living with psychosis and social disability. The ISRCTN record shows it as not yet recruiting.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- Sussex Partnership NHS Foundation Trust
- Condition
- Schizophrenia
Not Yet RecruitingISRCTN10648713
This feasibility study is preparing to test whether people can tell if they received psilocybin or placebo when the treatment acts during sleep. The ISRCTN record lists the study as not yet recruiting.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Depression
CompletedNCT05436613
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.
BipolarityOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- University of East London
- Condition
- Bipolarity
CompletedNCT05206734
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve sleep, daily rhythms, and longer-term stability.
DepressionOtherFrom 5 Years to 25 Years
- Countries
- United Kingdom
- Sponsor
- Momentum Data
- Condition
- Depression
SuspendedNCT06129500
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
BipolarityOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- University of Exeter
- Condition
- Bipolarity
TerminatedNCT05839509
This study exists to see whether the medication GH001 can play a useful role in care. Researchers are trying to understand what the medication GH001 could change in day-to-day care and decision-making.
BipolarityOtherFrom 18 Years to 64 Years
- Countries
- Germany, Netherlands, United Kingdom
- Sponsor
- GH Research Ireland Limited
- Condition
- Bipolarity
CompletedNCT02731612
This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 19 Years to 65 Years
- Countries
- Canada, Japan, United Kingdom, United States
- Sponsor
- Lakshmi N Yatham
- Condition
- Bipolarity
CompletedNCT05870501
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 18 Years to 55 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Depression
CompletedNCT03201757
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
SchizophreniaOtherFrom 16 Years to 70 Years
- Countries
- Austria, Bulgaria, Ireland, Israel, Italy, Poland, United States, Russian Federation, Serbia, South Korea, Ukraine, United Kingdom
- Sponsor
- Alkermes, Inc.
- Condition
- Schizophrenia
CompletedNCT01431326
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherUp to 21 Years
- Countries
- Canada, Israel, Singapore, United Kingdom, United States
- Sponsor
- Daniel Benjamin
- Condition
- Schizophrenia
CompletedNCT04134871
This study exists to see whether a medication treatment is workable and worth testing more broadly. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- Ireland, United Kingdom
- Sponsor
- University of Ulster
- Condition
- Schizophrenia
CompletedNCT05815459
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.
DepressionOtherFrom 18 Years to 40 Years
- Countries
- United Kingdom
- Sponsor
- Emteq Ltd
- Condition
- Depression
CompletedNCT04939818
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can better support energy, concentration, and everyday functioning.
DepressionOtherFrom 18 Years to 85 Years
- Countries
- United Kingdom
- Sponsor
- Novoic Limited
- Condition
- Depression
CompletedNCT02306551
This study exists to learn from real-world information that can show how this type of care fits into care. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
DepressionOtherOver 16 Years
- Countries
- Denmark, United Kingdom
- Sponsor
- Susanne Harder
- Condition
- Depression
CompletedNCT03187769
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
BipolarityOtherFrom 16 Years to 40 Years
- Countries
- Austria, Germany, Ireland, Israel, Italy, Poland, Russian Federation, South Korea, Spain, Ukraine, United Kingdom, United States
- Sponsor
- Alkermes, Inc.
- Condition
- Bipolarity
CompletedNCT04859647
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
BipolarityOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- University of Manchester
- Condition
- Bipolarity
CompletedNCT03959735
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
DepressionOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Depression
CompletedNCT03658824
This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.
BipolarityOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- University of Exeter
- Condition
- Bipolarity
CompletedNCT03534921
This study exists to explore whether questionnaires and follow-up reports could improve care and understanding. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.
Mental healthOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- University of York
- Condition
- Mental health
CompletedNCT01736644
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.
BipolarityOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- Medtronic Surgical Technologies
- Condition
- Bipolarity
CompletedNCT03013400
This study exists to compare options and see whether questionnaires and follow-up reports offers something meaningfully different. Researchers are trying to understand whether questionnaires and follow-up reports can better support energy, concentration, and everyday functioning.
BipolarityOtherFrom 18 Years to 70 Years
- Countries
- United Kingdom
- Sponsor
- University of Oxford
- Condition
- Bipolarity
CompletedNCT01765127
This study exists to see whether the medication Asenapine can make care clearer and more responsive. Researchers are trying to understand whether the medication Asenapine can give earlier or clearer feedback during care.
BipolarityOther
- Countries
- United Kingdom
- Sponsor
- Professor Saad Shakir
- Condition
- Bipolarity
CompletedNCT01734278
This study exists to learn from real-world information that can show how the medication Asenapine fits into care. Researchers are trying to understand how people respond to the medication Asenapine in practice and what may need to be adjusted.
BipolarityOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- Professor Saad Shakir
- Condition
- Bipolarity
